Opyl Ltd. ( (AU:OPL) ) just unveiled an update.
Opyl Limited announced a late lodgement of a ‘Change of Director’s Interest Notice’ for director Antanas Guoga, related to shares and options acquired in December 2024 and March 2025. The delay was due to an administrative oversight, which the company has addressed, asserting that their current compliance practices are adequate and the incident is isolated.
More about Opyl Ltd.
Opyl Limited is an AI company focused on transforming clinical trials and medical research through data and technology. The company is committed to innovation and strategic growth, aiming to shape the future of healthcare solutions.
YTD Price Performance: 65.00%
Average Trading Volume: 220,410
Technical Sentiment Signal: Hold
Current Market Cap: A$6.37M
See more insights into OPL stock on TipRanks’ Stock Analysis page.